UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction

Mbisa, JL; Kirwan, P; Tostevin, A; Ledesma, J; Bibby, DF; Brown, A; Myers, R; ... UK HIV Drug Resistance Database; + view all (2019) Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction. Clinical Infectious Diseases , 69 (7) pp. 1136-1143. 10.1093/cid/ciy1048. Green open access

[thumbnail of ciy1048(1).pdf]
Preview
Text
ciy1048(1).pdf - Accepted Version

Download (599kB) | Preview

Abstract

Background: Drug-resistant minority variants (DRMinVs) detected in patients who recently acquired HIV-1 can be transmitted, generated de novo through virus replication, or technical errors. The first are likely to persist and result in treatment failure while the latter two could be stochastic and transient. Methods: Ultra-deep sequencing of plasma samples from 835 individuals with recent HIV-1 infection in the UK was performed to detect DRMinVs at mutation frequency between 2-20%. Sequence alignments including >110,000 HIV-1 partial pol consensus sequences from the UK HIV Drug Resistance Database (UK-HDRD) , linked to epidemiological and clinical data from the HIV and AIDS Reporting System (HARS),were used for transmission cluster analysis. Transmission clusters were identified using Cluster Picker with a clade support of >90% and maximum genetic distances of 4.5% or 1.5%, the latter to limit detection to likely direct transmission events. Results: Drug-resistant majority variants (DRMajVs) were detected in 66 (7.9%) and DRMinVs in 84 (10.1%) of the recently infected individuals. High levels of clustering to sequences in UK-HDRD were observed for both DRMajV (n=48; 72.7%) and DRMinV (n=63; 75.0%) sequences. Of these, 43 (65.2%) with DRMajVs were in a transmission cluster with sequences that harboured the same DR mutation compared to only 3 (3.6%) sequences with DRMinVs (p<0.00001; Fisher's exact test). Evidence of likely direct transmission of DRMajVs was observed for 25/66 (37.9%) whereas none was observed for the DRMinVs (p<0.00001). Conclusions: Using a densely sampled HIV-infected population we show no evidence of DRMajV-to-DRMinV transmission or vice versa among recently infected individuals.

Type: Article
Title: Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/cid/ciy1048
Publisher version: http://doi.org/10.1093/cid/ciy1048
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: HIV-1, Drug-resistant minority variants, recent infection, transmission cluster, replication fitness
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10064668
Downloads since deposit
7,448Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item